261 related articles for article (PubMed ID: 27342958)
1. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
Freedman BI; Gadegbeku CA; Bryan RN; Palmer ND; Hicks PJ; Ma L; Rocco MV; Smith SC; Xu J; Whitlow CT; Wagner BC; Langefeld CD; Hawfield AT; Bates JT; Lerner AJ; Raj DS; Sadaghiani MS; Toto RD; Wright JT; Bowden DW; Williamson JD; Sink KM; Maldjian JA; Pajewski NM; Divers J
Kidney Int; 2016 Aug; 90(2):440-449. PubMed ID: 27342958
[TBL] [Abstract][Full Text] [Related]
2. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
[TBL] [Abstract][Full Text] [Related]
3. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
Freedman BI; Langefeld CD; Lu L; Palmer ND; Smith SC; Bagwell BM; Hicks PJ; Xu J; Wagenknecht LE; Raffield LM; Register TC; Carr JJ; Bowden DW; Divers J
Kidney Int; 2015 Jan; 87(1):176-81. PubMed ID: 25054777
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
Langefeld CD; Divers J; Pajewski NM; Hawfield AT; Reboussin DM; Bild DE; Kaysen GA; Kimmel PL; Raj DS; Ricardo AC; Wright JT; Sedor JR; Rocco MV; Freedman BI;
Kidney Int; 2015 Jan; 87(1):169-75. PubMed ID: 25029429
[TBL] [Abstract][Full Text] [Related]
6.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes.
Freedman BI; Divers J; Whitlow CT; Bowden DW; Palmer ND; Smith SC; Xu J; Register TC; Carr JJ; Wagner BC; Williamson JD; Sink KM; Maldjian JA
Diabetes Care; 2015 Nov; 38(11):2158-65. PubMed ID: 26370382
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
[TBL] [Abstract][Full Text] [Related]
10. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
Weiner DE; Gaussoin SA; Nord J; Auchus AP; Chelune GJ; Chonchol M; Coker L; Haley WE; Killeen AA; Kimmel PL; Lerner AJ; Oparil S; Saklayen MG; Slinin YM; Wright CB; Williamson JD; Kurella Tamura M;
Am J Kidney Dis; 2017 Sep; 70(3):357-367. PubMed ID: 28606731
[TBL] [Abstract][Full Text] [Related]
12. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
[TBL] [Abstract][Full Text] [Related]
13. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
14. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
15. Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
Sink KM; Divers J; Whitlow CT; Palmer ND; Smith SC; Xu J; Hugenschmidt CE; Wagner BC; Williamson JD; Bowden DW; Maldjian JA; Freedman BI
Diabetes Care; 2015 Feb; 38(2):206-12. PubMed ID: 25205141
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
Murea M; Hsu FC; Cox AJ; Hugenschmidt CE; Xu J; Adams JN; Raffield LM; Whitlow CT; Maldjian JA; Bowden DW; Freedman BI
Nephrol Dial Transplant; 2015 Aug; 30(8):1322-9. PubMed ID: 25722384
[TBL] [Abstract][Full Text] [Related]
17. APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
McLean NO; Robinson TW; Freedman BI
Am J Kidney Dis; 2017 Aug; 70(2):281-289. PubMed ID: 28143671
[TBL] [Abstract][Full Text] [Related]
18. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
[TBL] [Abstract][Full Text] [Related]
19. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
20. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
Hoy WE; Hughson MD; Kopp JB; Mott SA; Bertram JF; Winkler CA
J Am Soc Nephrol; 2015 Dec; 26(12):3179-89. PubMed ID: 26038529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
